阅读说明：本技术 一种基于量子隐形传态编译基因治疗药物的方法及应用 (Method for compiling gene therapy medicine based on quantum invisible state transfer and application ) 是由 万继华 于 2021-06-02 设计创作，主要内容包括：本发明涉及生量子生物信息学,具体说是一种基于量子隐形传态编译基因治疗药物的方法及应用,其中基于量子隐形传态编译基因治疗药物的方法,是以核酸链为载体测量碱基分子序列,再设定基因信息编译的靶标与靶向,然后以物理人为施加或化学诱导产生的量子隐形传态,将靶向中所含碱基的量子比特信号序列,编译成为与靶标所含量子比特信号相同或相反的序列；获得与靶标所含量子比特信号及其碱基分子序列相同或相反的目的基因信息序列。本发明改变了传统分子学方法,只能通过实体之间的直接化学或物理作用形成实体性反应,而本发明所述隐形传态方法,则可通过存在于分子中的物理信号的量子隐形计算而使实体分子发生突变,从而达到满足可治疗和防御基因疾病的技术性目标。(The invention relates to the bioinformatics of living quantum, it is a method and application based on that the stealthy state of quantum is compiled the gene therapy medicine specifically, wherein the method based on that the stealthy state of quantum is compiled the gene therapy medicine, measure the molecular sequence of basic group with the nucleic acid chain as the carrier, presume target and targeting that the gene information is compiled, then stealthy state of quantum that is produced by physical man-made application or chemical induction, compile the quantum bit signal sequence of basic group that is contained in targeting into the sequence the same as or opposite to quantum bit signal that is contained in the target; and obtaining the target gene information sequence which is the same as or opposite to the quantum bit signal and the base molecule sequence thereof contained in the target. The invention changes the traditional molecular method, and can only form entity reaction through direct chemical or physical action between entities, while the invisible state transfer method of the invention can cause the entity molecules to mutate through quantum invisible calculation of physical signals existing in the molecules, thereby achieving the technical goal of meeting the treatment and defense of gene diseases.)

1. A method for compiling a gene therapy medicine based on quantum invisible state transfer is characterized by comprising the following steps:

(1) taking RNA or DNA nucleic acid chains of human bodies, viruses or other organisms as information carriers, measuring information sequences of base molecules or quantum bit pairs contained in the base molecules, or designing and compiling the information sequences of the base molecules and the quantum bit pairs contained in the RNA and/or DNA based on quantum invisible states generated by chemical induction or artificially applied by physics based on the measured information sequences of the base molecules or the quantum bit pairs contained in the base molecules;

(2) setting the target and target for coding gene therapy medicine;

(3) compiling the sequence of the targeted RNA nucleic acid base molecule into a nucleic acid base sequence which is the same as or opposite to or partially the same as or opposite to the sequence of the target normally contained base molecule, or taking the DNA of the RNA sequence paired with the antisense strand as the targeted nucleic acid sequence, or directly taking the DNA sequence which is the same as or opposite to or paired with the antisense strand as the targeted nucleic acid base molecule sequence;

(4) obtaining targeted RNA or DNA, and preserving the RNA or DNA nucleic acid chain as a carrier, or/and preparing the targeted RNA or DNA nucleic acid chain into a nucleic acid medicament.

2. The method for compiling a gene therapy drug based on quantum invisible states of claim 1, wherein: the target of gene disease treatment refers to nucleic acid medicine for treating gene disease, and the target of gene disease treatment refers to gene DNA or RNA nucleic acid sequence treated or modified by the nucleic acid target medicine.

3. The method for compiling a gene therapy drug based on quantum invisible states of claim 1, wherein: the quantum invisible state compilation generated by chemical induction refers to coupling invisible compilation that enables a quantum bit pair signal contained in an RNA nucleic acid base molecule and a quantum bit pair signal contained in other RNA or DNA or scattered base molecules to be paired with a positive signal and a negative signal in a natural invisible quantum entanglement algorithm in a chemical environment by a primer or other chemical methods, and the quantum invisible state compilation artificially applied by physics is that in a set physical quantum computing system, the quantum bit pair signal in gene RNA or DNA which is targeted or targeted is mutated into invisible compilation which is the same as or opposite to a signal sequence coded in the computing system in a radiation-generated quantum entanglement algorithm by physical radiation.

4. The method for compiling a gene therapy medicine based on quantum invisible states of the human body according to claim 1, wherein the targeted nucleic acid medicine comprises three nucleic acid medicines for treating human body diseases caused by human body or biological DNA variation thereof and RNA infectious viruses and preventing RNA infectious viruses.

5. The method for compiling a gene therapy medicine based on quantum invisible states of transmission according to any one of claims 1 to 4, wherein the target nucleic acid medicine for treating DNA variation of the human body or the organism thereof is an RNA nucleic acid molecule sequence which is obtained by compiling a template mRNA of the human body or the organism thereof by a chemical or physical method and is the same as a normal template mRNA, and the target is a DNA nucleic acid molecule sequence of the human body or the organism thereof.

6. The method for coding gene therapy drugs based on quantum invisible state transfer according to any one of claims 1 to 4, characterized in that the target nucleic acid drug for treating RNA infectious virus is obtained by chemical or physical coding method to obtain RNA nucleic acid molecule sequence opposite to the sequence of viral RNA nucleic acid molecule, and the target is viral RNA nucleic acid molecule sequence.

7. The method for compiling a gene therapy medicine based on quantum invisible states of any one of claims 1 to 4, wherein the target nucleic acid medicine for preventing and treating RNA infectious viruses is a DNA nucleic acid molecule sequence obtained by polymerizing viral RNA and a sense strand thereof through a chemical or physical compiling method, and the target is a viral RNA nucleic acid molecule sequence.

8. Use of the method for compiling a gene therapy drug based on quantum invisible states according to any one of claims 1 to 7, wherein: the method is applied to legal and ethical permission of biological gene optimization, recombination, modification and treatment.

9. The use of a method for compiling a gene therapy drug based on quantum invisible states according to claim 8, wherein the method comprises: refers to applications targeting RNA or DNA that is optimized, recombined, modified, and treated, targeting RNA sequences compiled in physical systems or by chemical means; such applications include optimization, recombination, modification and therapeutic applications of animal and plant genes.

Technical Field

The invention relates to quantum bioinformatics, in particular to a method for compiling a gene therapy medicament based on quantum invisible state transfer and application.

Background

A gene compiling method based on quantum invisible state is a technical solution provided for the current epidemic infectious virus, such as new coronavirus, and a plurality of diseases which are generated on the gene information level and can not be effectively prevented and treated. Our theoretical studies found that the reason why the new coronavirus can not be effectively treated is that the modern scientific theory 'has a logic limitation problem that positive and negative properties can not be calculated'. Because the bottleneck problem causes that a logic algorithm model of gene disease treatment, cognitive artificial intelligence and quantum information calculation which needs to calculate yin-yang properties, true and false properties and positive and negative particles cannot be established, no calculable technical means is available for solving the problems. It can be seen that the basis for solving these problems lies in breaking through this algorithm bottleneck from theory. Therefore, an algorithm model and its related technical background for breaking through the theoretical bottleneck need to be waited for.

However, because of this algorithm, it is necessary to establish a new system complementary to the modern scientific calculation theory, and it is difficult to explain in an academic form and understand by professionals in the background of the existing theory and technology. As the papers published heretofore and the related patent solutions applied thereto have not been understood so far. The applicant prepares to read the general science popularization method, and makes the basic principle and the thought of the theory understood by all people and released and spread through the network, thereby making the common knowledge known by all people. Therefore, no treatment is made here.

Disclosure of Invention

Aiming at the technical problem that the prior biology and medicine thereof can not effectively treat gene diseases and infectious viruses thereof, the invention provides a method for compiling a gene therapy medicament based on quantum invisible state transfer, which comprises the following steps:

(1) taking RNA or DNA nucleic acid chains of human bodies, viruses or other organisms as information carriers, measuring information sequences of base molecules or quantum bit pairs contained in the base molecules, or designing and compiling the information sequences of the base molecules and the quantum bit pairs contained in the RNA and/or DNA based on quantum invisible states generated by chemical induction or artificially applied by physics based on the measured information sequences of the base molecules or the quantum bit pairs contained in the base molecules;

(2) setting the target and target for coding gene therapy medicine;

(3) compiling the sequence of the targeted RNA nucleic acid base molecule into a nucleic acid base sequence which is the same as or opposite to or partially the same as or opposite to the sequence of the target normally contained base molecule, or taking the DNA of the RNA sequence paired with the antisense strand as the targeted nucleic acid sequence, or directly taking the DNA sequence which is the same as or opposite to or paired with the antisense strand as the targeted nucleic acid base molecule sequence;

(4) obtaining targeted RNA or DNA, and preserving the RNA or DNA nucleic acid chain as a carrier, or/and preparing the targeted RNA or DNA nucleic acid chain into a nucleic acid medicament.

Preferably, the target of gene disease treatment refers to nucleic acid drugs for treating gene diseases, and the target of gene disease treatment refers to gene DNA or RNA nucleic acid sequences treated or modified by the nucleic acid targeted drugs.

Preferably, the chemically induced quantum invisible transition is coupled invisible transition in which a qubit pair signal contained in an RNA nucleic acid base molecule and a qubit pair signal contained in other RNA or DNA or a scattered base molecule are paired with each other by a primer or other chemical method in a natural invisible quantum entanglement algorithm, and the physically artificially applied quantum invisible transition is a quantum invisible transition in which a qubit pair signal in a targeted gene RNA or DNA is mutated by physical radiation in a set physical quantum computing system into a quantum state invisible transition identical to or opposite to a signal sequence encoded in the computing system in a radiation-generated quantum entanglement algorithm.

Preferably, the targeted nucleic acid drugs include three nucleic acid drugs for treating human diseases caused by human or biological DNA variation thereof and infectious RNA virus, and preventing infectious RNA virus.

Preferably, the targeted nucleic acid drug for treating human body or biological DNA variation thereof is an RNA nucleic acid molecule sequence which is obtained by coding a template mRNA of the human body or biological thereof by a chemical or physical method and is the same as a normal template mRNA, and the target is a variant DNA nucleic acid molecule sequence of the human body or biological thereof.

Preferably, the target nucleic acid medicament for treating the RNA infectious virus is obtained by a chemical or physical coding method to obtain an RNA nucleic acid molecule sequence opposite to the sequence of the viral RNA nucleic acid molecule, and the target is the sequence of the viral RNA nucleic acid molecule.

Preferably, the target nucleic acid medicament for preventing and treating the RNA infectious virus is a DNA nucleic acid molecule sequence obtained by polymerizing virus RNA and an antisense strand thereof by a chemical or physical coding method, and the target is the virus RNA nucleic acid molecule sequence.

According to the scheme, the invention changes the pathological and pharmacological meanings of the current nucleic acid targeted drugs based on the quantum invisible state, the gene DNA and/or RNA are used as targets, and the targeted quantization treatment method is adopted. The current method is molecular in etiology, while the present solution is quantum information. From the pharmacological point of view, the current nucleic acid-based targeted drugs aim to suppress the inability of variant proteins to synthesize variant cells. In the scheme, the mutant protein and cells are not synthesized after the DNA or RNA is modified. Since proteins are synthesized from mRNA calculated from the triplet of 64 codons and encoded by its genetic material, erroneous information from DNA or RNA, i.e., the source of the disease, is resolved, and the disease at the genetic information level is naturally resolved. Based on the quantum information principle, the method for converting positive to negative by neutralizing yin and yang in a quantization level by using an RNA single-stranded infectious virus such as an antisense strand of a Xinguan as a targeted drug is well understood. Thus, the technical features and principles of this improvement, and the effectiveness of the method of application thereof, are well understood.

The invention also provides application of the method for compiling the gene therapy medicine based on the quantum invisible state transfer, which is applied to legal and ethical allowable biological gene optimization, recombination, modification and treatment.

Preferably, it refers to applications targeting RNA sequences compiled in physical systems or by chemical means, targeting RNA or DNA to be optimized, recombined, modified and treated; such applications include optimization, recombination, modification and therapeutic applications of animal and plant genes.

The invention is realized by a method for optimizing, recombining and modifying biological genes by a physical quantum invisible calculation or chemical compiling means and a method for compiling gene therapy medicines by quantum invisible state.

Detailed Description

The present invention will be described in detail with reference to examples. The invention provides a method for compiling a gene therapy medicament based on quantum invisible state transfer, which comprises the following steps:

(1) taking RNA or DNA nucleic acid chains of human bodies, viruses or other organisms as information carriers, measuring information sequences of base molecules or quantum bit pairs contained in the base molecules, or designing and compiling the information sequences of the base molecules and the quantum bit pairs contained in the RNA and/or DNA based on quantum invisible states generated by chemical induction or artificially applied by physics based on the measured information sequences of the base molecules or the quantum bit pairs contained in the base molecules;

this step is the basis, and in fact, it is the signal data that is first known about the base molecule sequence of the gene being coded. For example, in a human body, a disease or a malignant disease is caused by a variation in molecular sequence in a gene DNA sequence, and then, the first step is to detect the DNA sequence and compare it with its normal sequence to confirm whether the disease is caused by the DNA sequence variation. Currently, there is no diagnosis by gene sequencing methods because current chemical sequencing methods are limited in cost and time. It is found by this theory that subsequent sequencing can improve the reading of data on microfluidic chips. This is not limited by cost and time. A method for realizing gene sequencing by only reading base molecule signals is proposed in a patent application of 'a physical method for detecting gene information and sequencing thereof'. For another example, if the treatment with antisense nucleic acid drugs is considered, the new coronavirus expressed by RNA nucleic acid is sequenced from the beginning, and only if the sequence of the virus chain is obtained, the method for obtaining the antisense nucleic acid chain can be designed according to the sequence.

(2) Setting the target and target for coding gene therapy medicine.

The key is that the theoretical algorithm and the natural law are followed by the scheme, and the same photon bosons like coins calculate the own quantization law by the own positive and negative information. The base molecules in the DNA and the RNA respectively contain coding information expressed by the qubit pairs, and the yin-yang properties of the base molecules, namely the properties of the purines and the pyrimidines, are determined by the yin-yang information expressed by the qubit pairs by signals 1 and 0. Therefore, under the condition of quantum invisible state, i.e. natural quantum invisible algorithm, the property of the target nucleic acid and the sequence thereof, which are therapeutic targets, is changed or neutralized through the normal or antisense information sequence in the target, and the effective method for changing the sequence property of the target nucleic acid and the molecular sequence thereof by following the natural law is provided. Thus changing the target of the current nucleic acid targeting drugs to be proteins and cells, namely breaking the variant proteins into variant cells. Thus, the problem of the source of the disease is not fundamentally solved. For example, when a person develops genetic diseases such as water leakage of a dam, the current treatment method is to stop the leakage outside the dam, and the method of the scheme is to stop the leakage inside the dam. This distinction and effect is intuitive. In addition, for the quantum invisible state and the entanglement algorithm thereof, the principle that the same photon boson hides the positive and negative information like the coin spin and calculates the positive and negative information is unknown, so that the scheme based on the quantum invisible state cannot be provided. Further, there is no method for preventing and treating the disease by converting the positive into negative by the neutralization of yin and yang after the RNA infectious virus nucleic acid and antisense RNA are polymerized into DNA. That is, this key step embodies the theoretical and technical principles of how to treat and protect against genetic diseases.

(3) The sequence of the targeted RNA nucleic acid base molecule is compiled into the nucleic acid base sequence which is the same as or opposite to or partially same as or opposite to the sequence of the target normally contained base molecule, or the RNA sequence and the DNA of the antisense strand are paired to form the targeted nucleic acid sequence, or the DNA sequence which is the same as or opposite to or paired with the antisense strand is directly used as the targeted nucleic acid base molecule sequence.

This step is the method of implementation. For example, we set the nucleic acid sequence of the novel crown RNA as the target, and then according to the concept and method of this scheme, the antisense RNA nucleic acid is used as the target drug for treatment. Therefore, it is necessary to compile a qubit signal sequence of a base contained in a target into a sequence opposite to a qubit signal contained in the target by quantum stealth states generated by physical artificial application or chemical induction. This makes it possible to obtain the sequence of the information molecule for the preparation of a targeted nucleic acid drug for the treatment of its viral RNA. In another example, since a protein encoded by template RNA melted by a large variation in the base molecular sequence of human DNA and cells naturally vary, the normal mRNA is subjected to reverse transcription with a reverse transcriptase or the like, and the varied DNA is matched with the reverse transcribed normal mRNA in a quantized state having memory, thereby restoring the normal state. When the DNA is normal, the protein and cells encoded by the mRNA melted by the DNA are naturally restored to normal. Also, if there is a genetic disease in a human gene and a treatment is required, it is necessary to physically or chemically treat a part of the signal in the template mRNA as a target, in such a manner that the property of the signal at the part site becomes the same as or opposite to that of the signal in the target.

The quantum invisible state transfer between the target and the entanglement calculation thereof are completed in a radioactive device or an environment with radioactive conditions. The rule of six-photon entanglement identity or algorithm between the target and the target is a triplet algorithm in which the signal sequence of the target and the signal sequence of the target are the same, unchanged and inverted, so that the signal sequence of the qubit pair in the target becomes the same as the signal sequence of the qubit pair in the target. The xor algorithm rule of six-photon entanglement between the target and the target is a triplet algorithm that the signal sequence of the qubit pair in the target is the same as, the inverse of, and the same as the signal sequence of the target, so that the signal sequence of the qubit pair in the target becomes the opposite of the signal sequence of the qubit pair in the target. The computational compiling method can be widely applied to the optimization, recombination and treatment of biological genes.

The invention also provides a method for optimizing, recombining and modifying the biological gene by a physical quantum invisible calculation or chemical compiling means. It is characterized by being realized by a method for compiling gene therapy medicines in a quantum invisible state.

The following illustrates the implementation process:

example 1: if there is a large variation in the base sequence in the human DNA, there is a variation in the entire system of the human body, i.e., a lesion or malignant lesion. Because 20 kinds of ammonium acid in human body are all encoded by using single-strand mRNA after double-strand melting of DNA as a template and using a structure that three adjacent bases on the template are one codon. Proteins in the human body are synthesized from ammonium acid and then form cells and organs as well as the human body. It can be seen that the human body acts as a carrier of life, and from the viewpoint of biological information, its roots are in the base molecules of DNA and template mRNA, and the signal sequence of the qubit pair in which this molecule is controlled.

If the DNA causes the information on the template mRNA to be mutated, for example, the normal should be 10-10-11-10-01-01-00, but the result is 10-11-00-10-01-01-01, i.e., the 2 nd, 3 rd and 7 th mutations therein. If the cells are not recovered, the corresponding human cells are mutated. It is restored. There are two physical and chemical methods of recovery. The technical core of the two methods is a quantum invisible state transfer method taking normal information as a target and taking variation information as a target. The two methods differ in that the targets and targets used by physical methods are qubit signals, while the targets and targets used by chemical methods are base molecules and their nucleic acid vectors that contain the qubit signals.

The physical method can adopt quantum bit wave expressing normal signal sequence to radiate to human body, and the radiation is completed in the radiotherapy instrument. Specifically, in a single-photon quantum invisible computing system, the method is realized by a quantum invisible triplet algorithm which is targeted to be the same as and unchanged from a target signal and is different from the target signal. The principle is the same as that of genetic variation caused by nuclear energy wave, namely quantum bit wave, of nuclear leakage. Since the code in the nuclear leakage radiation wave is different from the human body sequence, dissimilarity is caused. The radiation of energy waves with the same normal code of the human body naturally leads to the assimilation of the dissimilatory code and the normal code in the human body.

Specifically, between the target 10-10-11-10-01-01-00 and the target 10-11-00-10-01-00, using an algorithm of a logic same or triple channel in which each of the two signals is not turned back or changed, i.e., |1 > 1 |, 1 > 0 |0 > 0 |1 |, 0 |0 > 0 |1 > 1 |0 |, 0 |, and 0 |, an algorithm of an equal to or greater than 0 |, respectively, in which each of the signals in the target becomes the same as the signal sequence of the target. By the algorithm in the radiation process, different signals of the target and the target are assimilated in the latent state of the photon boson. That is, the qubit signals of the target and the target are different, and become the same as 10-10-11-10-01-01-00 of the target signal. Since the qubit information of the control base molecule is changed, the base molecule is mutated accordingly. That is, the base molecule in the target is mutated from 10G-11T-00A-10G-01C-01C-00A corresponding to the signal before calculation to be identical to the targeted sequence 10G-10G-11T-10G-01C-01C-01C.

There is also a physical method, which is to extract the mutated human cell DNA, prepare it into mRNA nucleic acid chain, and then prepare the nucleic acid target drug combined with the reverse transcriptase after the target sequence is recovered to normal by the irradiation method. This drug is useful both therapeutically and in the defense against DNA variations. The physical method can also be used for preparing medicine for treating infectious virus such as neocoronary pneumonia. Specifically, the sequence of the quantum bit signal contained in the base in the virus RNA nucleic acid chain is used as target radiation. If the RNA sequence of the novel coronavirus is 00-10-01-11-11-01-01, the antisense sequence should be 11-01-10-00-00-10-10. The same inversion and different invariance of the exclusive-or triplet algorithm is applied to each of the two signals, i.e., |1 ^ 0 ^ 1 ^ 0 ^ 1 ^ so that each signal in the target becomes opposite to the signal sequence of the sample. Since each signal in the target is different from the signal in the target, the sequence of the viral RNA is dissimilated to the opposite strand in the quantum crypto state of the single photon vitroneum. I.e., the qubit signal in the target becomes identical to the antisense strand 11-01-10-00-00-10-10 in the target. As the qubit information of the control base molecule is changed, the viral base molecule is correspondingly mutated to the antisense strand. Then preparing the virus into a nucleic acid targeted medicament for treating the virus. For example, the antisense strand of RNA neocoronaviruses can be obtained by this method and can be used for treating neocoronaviruses. The two are polymerized into DNA nucleic acid, so that the vaccine for defending against the new coronary pneumonia can be prepared.

Example 2: the chemical method comprises a quantum invisible state transfer method aiming at DNA and RNA. The DNA method is that nucleic acid medicine is prepared with normal mRNA nucleic acid and reverse transcriptase component, and the normal mRNA reverse transcription mechanism is matched with variant DNA, so that the wrong or variant base and its signal are corrected or replaced during the coupling with normal mRNA. Memory effects using macylarina particles are included herein. Because the normal mRNA is personal and the quantized particles, namely the physical carrier of the quantum bit information, is memorized, the original position of the mangrove particles in the basic groups of the normal mRNA can be found through the memory of the mangrove particles, and the mutated DNA can be recovered to be normal. If the DNA is normal, the mRNA melted from it is normal. This is a chemical approach targeting normal mRNA and targeting mutated DNA.

The method for compiling antisense nucleic acid medicine by using chemical means is characterized by that it uses the RNA strain of virus RNA chain, for example new coronavirus, and makes it and other RNA and DNA undergo the process of coupling action of quantum bit signal in its molecular sequence and polymerize them into DNA, then makes them melt so as to obtain the invented product. Then, the antisense nucleic acid chain is prepared into medicine, which can be used as medicine for treating the RNA virus. If the new coronavirus can be used for treating by antisense nucleic acid medicine, and the DNA nucleic acid chain can be prepared into vaccine medicine. The principle is that the human body can replicate the antisense information response of the human body to the invaded virus strain through the antisense information in the human body, and thus an antibody is formed.

The above embodiments are provided only for illustrating the present invention and not for limiting the present invention, and those skilled in the art can make various changes and modifications without departing from the spirit and scope of the present invention, and therefore all equivalent technical solutions should also fall within the scope of the present invention.